# FDA Inspection 702994 - The Arthur G. James Cancer Hospital and the Richard J Solove Research Institute Blood and Marrow Transplant Program - December 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/the-arthur-g-james-cancer-hospital-and-the-richard-j-solove-research-institute-blood-and-marrow-transplant-program/bccec6e1-8047-4028-ad18-7df838dccdfb
Source feed: FDA_Inspections

> FDA Inspection 702994 for The Arthur G. James Cancer Hospital and the Richard J Solove Research Institute Blood and Marrow Transplant Program on December 17, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 702994
- Company Name: The Arthur G. James Cancer Hospital and the Richard J Solove Research Institute Blood and Marrow Transplant Program
- Inspection Date: 2010-12-17
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 810178 - 2012-12-11](https://www.keypedia.com/records/fda_inspections/the-arthur-g-james-cancer-hospital-and-the-richard-j-solove-research-institute-blood-and-marrow-transplant-program/a81ac6d0-d6a3-4b13-bfc6-03a97e2dbcee)

Company: https://www.keypedia.com/companies/the-arthur-g-james-cancer-hospital-and-the-richard-j-solove-research-institute-blood-and-marrow-transplant-program/c18460f0-54fe-42d7-9391-cf3145709a2e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d